The LENSAR Laser System, designed to help surgeons perform precise corneal and arcuate incisions during refractive cataract surgery, has earned FDA 510(k) clearance.
Ophthalmology
InSite Vision has earned $15 million for future royalties of Besivance, its pink-eye antibacterial eye drop, according to a San Francisco Business Times report.
Medifirst Solutions, a New Jersey and Florida-based distributor of healthcare products and services, has announced the addition of Kenneth R. Pearlberg, MD, to its advisory board.
Devers Eye Institute in Portland, Ore., offers its patients corneal crosslinking, a treatment designed to slow post-LASIK ectasia and keratoconus, according to The Lund Report.
IRIDEX, a Mountain View, Calif.-based ophthalmology device company, has announced a partnership with New Britain, Pa.-based Peregrine Surgical to expand its ophthalmology product portfolio.
Advertisement
MacuLogix, an ophthalmic diagnostics company based in Hummelstown, Pa., has announced it is aiming to raise $5 million in Series B funding, according to a DOWJONES report.
Steven Feldon, MD, the director of University of Rochester Medical Center Flaum Eye Institute, has been named president of the Association of University Professors of Ophthalmology.
Eye Excellence's Mary Green, MD, a board-certified ophthalmologist, has been received the 2012 Sightpath Top Surgeon award.
Bausch + Lomb's experimental glaucoma medication, BOL 303259-X, has shown a greater reduction of intraocular pressure than the current standard glaucoma treatment, latanoprost, according to a Medscape report.
The New York Ear and Eye Infirmary recently published a study showing Diopsys NOVA-LX Visual Evoked Potential Vision Testing System to be an effective tool in the early detection of glaucoma.